Alnylam Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US02043Q1076

SecurityALNY / Alnylam Pharmaceuticals, Inc.
InstitutionBlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I
Latest Disclosed Ownership151 shares
Latest Disclosed Value $ 49,239
BlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I ownership in ALNY / Alnylam Pharmaceuticals, Inc.

On August 28, 2025 - BlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I filed a NPORT-P form disclosing ownership of 151 shares of Alnylam Pharmaceuticals, Inc. (US:ALNY) valued at $49,240 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 151 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $46,137 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-28 2025-06-30 NP Alnylam Pharmaceuticals EC US02043Q1076 151 0 0.00 49 22.50 0.0324
2025-05-27 2025-03-31 NP Alnylam Pharmaceuticals EC US02043Q1076 151 0 0.00 41 14.29 0.0272
2025-02-27 2024-12-31 NP Alnylam Pharmaceuticals EC US02043Q1076 151 -207 -57.82 36 -64.29 0.0220
2024-11-26 2024-09-30 NP Alnylam Pharmaceuticals EC US02043Q1076 358 -408 -53.26 98 -47.31 0.0605
2024-08-27 2024-06-30 NP Alnylam Pharmaceuticals EC US02043Q1076 766 -86 -10.09 186 46.46 0.1126
2024-05-28 2024-03-31 NP Alnylam Pharmaceuticals EC US02043Q1076 852 770 939.02 127 746.67 0.0744
2024-02-27 2023-12-31 NP Alnylam Pharmaceuticals EC US02043Q1076 82 82 16 0.0094
2023-08-25 2023-06-30 NP Alnylam Pharmaceuticals EC US02043Q1076 0 -113 -100.00 0 -100.00
2023-05-26 2023-03-31 NP Alnylam Pharmaceuticals EC US02043Q1076 113 24 26.97 23 4.76 0.0134
2023-02-24 2022-12-31 NP Alnylam Pharmaceuticals EC US02043Q1076 89 -76 -46.06 21 -36.36 0.0121
2022-11-28 2022-09-30 NP Alnylam Pharmaceuticals EC US02043Q1076 165 -163 -49.70 33 -29.79 0.0194
2022-08-26 2022-06-30 NP Alnylam Pharmaceuticals EC US02043Q1076 328 0 0.00 48 -11.32 0.0269
2022-05-25 2022-03-31 NP Alnylam Pharmaceuticals EC US02043Q1076 328 255 349.32 54 341.67 0.0270
2022-02-25 2021-12-31 NP Alnylam Pharmaceuticals EC US02043Q1076 73 -151 -67.41 12 -58.62 0.0058
2021-02-24 2020-12-31 NP Alnylam Pharmaceuticals EC US02043Q1076 224 61 37.42 29 26.09 0.0130
2020-11-24 2020-09-30 NP Alnylam Pharmaceuticals EC US02043Q1076 163 -159 -49.38 24 -51.06 0.0112
2020-08-24 2020-06-30 NP Alnylam Pharmaceuticals EC US02043Q1076 322 -381 -54.20 48 -38.16 0.0228
2020-05-26 2020-03-31 NP Alnylam Pharmaceuticals EC US02043Q1076 703 194 38.11 77 31.03 0.0377
2020-02-25 2019-12-31 NP Alnylam Pharmaceuticals EC 02043Q107 509 -227 -30.84 59 -1.69 0.0248
2019-11-25 2019-09-30 NP Alnylam Pharmaceuticals EC US02043Q1076 736 736 59 0.0252
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.